Innospec Q3 2026 Earnings Call Transcript

Innospec (NASDAQ:IOSP) reported third-quarter financial results on Wednesday. The transcript from the company’s third-quarter earnings call has been provided below.

This transcript is brought to you by Benzinga APIs. For real-time access to our entire catalog, please visit https://www.benzinga.com/apis/ for a consultation.

Access the full call at https://edge.media-server.com/mmc/p/uenrahcr/

Summary

Innospec Inc reported strong financial performance with total revenues of $473.6 million, a 7% increase from the previous year, and a significant rise in net income to $31.8 million from $12.9 million.

Performance Chemicals saw a substantial 84% increase in operating income, driven by improved sales and gross margin. Plant upgrades in North Carolina are expected to further boost growth by year-end.

Fuel Specialties and Oilfield Services also reported revenue and operating income growth, though Oilfield Services was impacted by delays in the Middle East. Sequential improvement is expected in the fourth quarter.

The company’s cash position remains strong with $251.9 million and no debt, allowing for flexibility in investment and shareholder returns. A dividend increase of 9% was approved.

Management remains optimistic about future growth, focusing on product innovation and operational efficiency, and anticipates stronger cash generation in the coming quarters.

Full Transcript

David Jones (Senior Vice President, General Counsel, Chief Compliance Officer & Corporate Secretary)

Events. These statements are based on current expectations and assumptions that are subject to risks and uncertainties that could cause actual results to differ materially from the anticipated results implied by such forward-looking statements. The risks and uncertainties are detailed in Innospec’s filings with the SEC. Please see the SEC site and Innospec site for these and related documents. In today’s presentation, we’ve also included non-GAAP financial measures. A reconciliation to the most directly comparable GAAP financial measure is contained in the earnings release. The non-GAAP financial measures should not be considered as a substitute for those prepared in accordance with GAAP. They are included as additional items to aid investor understanding of the Company’s performance in addition to the impact that these items and events had on financial results.

With me today from Innospec are Patrick Williams, President and Chief Executive Officer, and Ian Cleminson, Executive Vice President & Chief Financial Officer. And with that, I’ll turn it over to you, Patrick.

Patrick S. Williams (Chief Executive Officer)

Thank you, David, and welcome everyone to Innospec’s third quarter 2026 conference call. This was a strong quarter for Innospec with all businesses delivering sales growth and operating income improvement. Performance Chemical sales growth and gross margin improvement drove an 84% operating income increase over last year. Plant efficiency upgrades in North Carolina discussed last quarter are scheduled to be completed by year-end. These upgrades will increase capacity, productivity, and yields on a wide range of existing personal care and other products. In parallel, we will continue to focus on commercializing new products to drive further margin and operating income improvement in the coming quarters.

Fuel Specialties had another strong quarter delivering revenue and operating income growth with margins in our target range. Both volume and price mix improved as the business has continued to manage well against raw material volatility. We expect continued strong performance and seasonal demand in the coming quarters. Oilfield Services operating income grew 40% and operating margins expanded, driven by improved volumes from our recent DRA plant expansion. Third quarter results were lower than expected on activity delays in our Middle East legacy business along with elevated raw material cost. We expect sequential improvement in the fourth quarter.

Now I will turn the call over to Ian Cleminson, who will review our financial results in more detail. Then I will return to some concluding comments. After that, Ian and I will take your questions.

Ian Cleminson (Executive Vice President & Chief Financial Officer)

Thanks, Patrick. Turning to Slide 7 in the presentation, the company’s total revenues for the third quarter were 473.6 million, a 7% increase from 441.9 million a year ago. Overall gross margin increased by 0.9 percentage points from last year to 27.3%. Adjusted EBITDA for the quarter was 51.4 million compared to 44.2 million last year, and net income attributable to Innospec for the quarter was 31.8 million compared to 12.9 million a year ago. Our GAAP earnings per share were $1.29 and there was no net impact of special items in the quarter.

Last year we reported GAAP earnings per share of $0.52, which included a negative impact from special items of $0.60 per share. Excluding special items in both years, our adjusted EPS for the quarter was $1.29 compared to $1.12 a year ago. Turning to Slide 8, revenues in Performance Chemicals for the third quarter were 180.5 million, up 6% from last year’s 170.8 million. Volume reductions of 5% and a negative currency impact of 1% were offset by a positive price mix of 12% driven by higher raw material pricing. Gross margins of 18.8% increased 3.7 percentage points compared to 15.1% in the same quarter in 2025. Operating income of 16.9 million increased 84% from 9.2 million last year.

We expect the fourth quarter results to be similar to this quarter with the plant upgrades in North Carolina the key to unlocking growth in 2027. Moving on to Slide 9, revenues in Fuel Specialties for the third quarter were 180.7 million, up 5% from 172 million reported a year ago. Volumes were up 3%, with price mix up 2%. Fuel Specialties gross margins of 31.5% decreased 0.5 percentage points compared to 35.6% in the same quarter last year. Operating income of 35.6 million was up 1% from 35.3 million a year ago.

Moving on to Slide 10, revenues in Oilfield Services for the quarter were 112.4 million, up 13% from the 99.1 million reported a year ago. Gross margins of 28.2% decreased 1.8 percentage points from last year’s 30% on a weaker sales mix. Operating income of 6.7 million increased 40% from 4.8 million one year ago. Turning to Slide 11, corporate costs for the quarter were 18.6 million compared with 18.2 million a year ago. The adjusted effective tax rate for the quarter was 24.7% compared to 22.7% last year.

Moving on to Slide 12, cash from operating activities were 17.4 million before capital expenditures of 15.6 million. As of September 30, Innospec had 251.9 million in cash and cash equivalents and no debt. And now I’ll turn it back over to Patrick for some final comments. Patrick.

Patrick S. Williams (Chief Executive Officer)

Thanks, Ian. Again this quarter, Innospec delivered strong sales and operating income growth with higher margins. Performance Chemicals and Oilfield Services remain our key focus. We expect continued steady and strong results in Fuel Specialties. Operating cash generation was positive in the quarter and our net cash position remained at over 250 million. We continue to focus on driving increased operating cash flow in the coming quarters with better working capital efficiency. We have significant balance sheet flexibility for organic investment, M&A, dividend growth, and buybacks. This quarter, our board approved a further increase in our semiannual dividend to $0.94 per share, resulting in an annual dividend increase of 9%.

Now I will turn the call over to the operator and Ian and I will take your questions.

OPERATOR

Thank you. To ask a question, you will need to press star, one, and one on your telephone and wait for your name to be announced. To withdraw your question, please press star, one, and one again. We are now going to take our first question, and this one comes from John Tawanteng from GGS Securities. Please go ahead.

John Tawanteng (Analyst at GGS Securities)

Hi, good morning. Thank you for taking my question. I was wondering if you could quantify the impact in the oilfield business from delays in the Mideast — and I’m assuming that that was pipeline attacks in Saudi — number one in the quarter, and number two, how you expect that business to trend in Q4, assuming a recovery there and the underlying inflation dynamics.

Patrick S. Williams (Chief Executive Officer)

Yeah, John, it’s Patrick. It wasn’t necessarily impacting the DRA business. More of the impact was on production and stim and, you know, it’s just the fact of getting people out in the fields to work while you’re having drones bombing over the top of you has been a very difficult situation for that whole area. And the key for us really is making sure that we’re back on these rigs when they go back out and that we’re servicing the way they need to be serviced.

The impact, you know, was probably not a significant percentage, but big enough to make a difference in oilfield. And the hope is, from what we’re seeing, as long as we service the customers as we expect and we have the technology, is that we’re starting to see some return in business in the fourth quarter, which should really help us out moving forward.

John Tawanteng (Analyst at GGS Securities)

Got it. And as you head into ’27, could you just update us on the outlook for the segment in the coming year, especially as you have potential customers coming in from Latin America and as the dynamic evolves from pipelines to maybe a reopening of the Strait or some other, you know, condition change in the Middle East?

Patrick S. Williams (Chief Executive Officer)

Yes, I’ll work backwards. If we just stick with the Middle East for a minute, I think that, you know, with everything that’s going on in that area and other businesses that we’re going after, our DRA should remain strong even if the straits — and we have settlements for the straits — are moved and we move forward. If you look at the general business, we’re still waiting to see things move in Latin America, specific to Mexico. I think you’ve seen some announcements by President Sheinbaum about opening up, putting more money into petrochemicals, and petrochemical facilities tend to do that. They’ve got to fix their crude issue. We’re hoping at some time that that turns. But we have not had any sales into Mexico to date.

So, you know, if we had the crystal ball, if all these things came into place, it would obviously look a lot different than it is today. But we still see significant growth — sequential growth as well — moving forward in, not quarter, but in the quarters coming forward in 2027.

John Tawanteng (Analyst at GGS Securities)

Okay, great. Next for me, could you just update us on your expectations for cash and cash flow? You know, you’ve come down on your net cash balance over the past year, and recognizing you return a lot of cash to shareholders — so great job there — but I was wondering if you had any thoughts on where your net cash balance is going to be over the coming year and how you expect the spending priorities to change, if at all.

Ian Cleminson (Executive Vice President & Chief Financial Officer)

Yeah, let me take that one, John. What we’ve seen so far year-to-date is quite a large investment in our working capital — that’s expanded by about 80 million since the start of the year. In the fourth quarter, we expect some of that to reverse. And what’s driven that is partly the expansion of the business and partly some of the inflation that we’ve seen coming through the supply chain in terms of raw materials and freights, and that works itself through.

But no doubt we’re probably carrying a little bit too much inventory. We can be a little bit tighter on some of those receivables. So we’ve got some work to do in the fourth quarter. Our view is that we will be much more cash generative in the fourth quarter to the region of about $40 to $50 million at the free cash flow level. So that takes care of this year. And as we roll into next year, our expectation is that we won’t need — on a stable background with raw materials relatively stable — we won’t need the same level of working capital investment. So we would imagine that we’ll be hitting closer to 55 to 60 million of free cash flow next year.

And that’s based on a pretty similar level of capital expenditure — round about 60 million last year and we expect about 60 million this year as well.

John Tawanteng (Analyst at GGS Securities)

Okay, great. Thank you, Ian.

Ian Cleminson (Executive Vice President & Chief Financial Officer)

No problem.

OPERATOR

Thank you. We are now going to take our next question, and this one is from Mike Harrison from Seaport Research Partners. Please go ahead.

Mike Harrison (Analyst at Seaport Research Partners)

Hi, good morning. Morning. Apologies if I missed it, but a couple questions on personal care. It sounds like the North Carolina plant upgrades are to be complete by year-end. I’m just wondering, has the timing moved later there and, if so, what’s causing the delays? And I guess the other piece of that question is, is there a requalification process that you need to go through with your customers, or should we see sales volumes kind of getting back to normal by Q1?

Patrick S. Williams (Chief Executive Officer)

Good morning, Mike. Yeah, Mike, we haven’t really — the timing has been about what we expected. The number one priority was to get the plants up and running so that we could provide products to our customers, and that’s what we did. The secondary part of the plan was to make sure that we concluded and finished the efficiencies of the plant to make it better — better yields, providing more volume because you have better yields, et cetera — winterizing it, all the things that we had to do.

Our number one priority was to get product to our customers, and so the timing of that is exactly what we thought, that we would complete all of this by the fourth quarter, and that should happen. So in regards to recapturing more products — or lost sales, I should say — it’s going to take some time. We don’t have to re-qualify, but it is going to take some time to go back and recapture some of that business. And that’s why we see this, you know, we do see sequential growth moving forward, but it’s just, it’s not going to be that big spike. It’s going to be a nice slow curve upwards. And I think the other thing that we’re focusing on too is the product mix that we put on that plant.

You know, we don’t want to just load it up with commodity products. We want new products, new technologies that require — or we get — higher margins from. And that’s really the plan moving forward. So it’s a plan we’ve had in place. We’re sticking to it. I think the strategy’s working and it should work moving forward in 2027.

Mike Harrison (Analyst at Seaport Research Partners)

All right, very helpful. And then my other question is on the Fuel Specialties business. You guys have these contractual pricing pass-throughs. It looks like price was only up about 2% year-on-year, despite what I assume was pretty meaningful raw material inflation. I was just hoping you could talk a little bit about the timing of that pricing pass-through and how that’s impacting the margins, either gross margin or operating margin, as you look at Fuel Specialties for Q3 and Q4.

Ian Cleminson (Executive Vice President & Chief Financial Officer)

Yeah, Mike, I’ll take that one. We think the Fuel Specialties team have done a good job, actually. They’ve been battling against some really volatile raw material pricing and freight pricing as well. We have managed the gross margins in that business really well. We are half a percentage point down year over year. And as you know, we’ve got all the mechanisms in place as raw materials come through, and there’s a little bit of a lag in there. So the level we’re at in the fourth quarter is the level we expect to be at in the fourth quarter.

We don’t see much change there. We think the business has got a handle on it and we’re in control of all of that. So I take your point that the price mix is not up that much, but certainly at the gross margin level and the gross profit dollars and the operating income level and the operating margin levels, we’re happy with where the business is at.

Patrick S. Williams (Chief Executive Officer)

Yeah, I think, Mike, just to add a little color to what Ian said, I started out with this business and ran this business for quite some time, and we have seen these markets up and down. We’ve seen high inflation, we’ve seen recessions, we’ve seen, you know, mega, mega market movements. And it’s never been these big run-ups on margins or big rundown on margins. It’s always very well managed and, you know, a lot of it’s contracts, but it’s a very well-managed margin business.

So you’re never going to see these big spikes in that business. It’s just a very stable business, and we’ve seen that for as long as we’ve been in it.

Mike Harrison (Analyst at Seaport Research Partners)

All right, thanks very much.

Patrick S. Williams (Chief Executive Officer)

Thanks, Mike.

OPERATOR

Thank you. There are no further questions for today. I will now hand the call back to Patrick Williams for closing remarks.

Patrick S. Williams (Chief Executive Officer)

Thank you all for joining us today, and thanks to all our shareholders, customers, and Innospec employees for your interest and support. If you have any further questions about Innospec or matters discussed today, please give us a call. We look forward to meeting up with you again to discuss our fourth quarter 2026 results in February. Have a great day.

OPERATOR

Thank you. This concludes today’s conference call. Thank you for participating. You may now disconnect.

Disclaimer: This transcript is provided for informational purposes only. While we strive for accuracy, there may be errors or omissions in this automated transcription. For official company statements and financial information, please refer to the company’s SEC filings and official press releases. Corporate participants’ and analysts’ statements reflect their views as of the date of this call and are subject to change without notice.